Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
33
LILA Quote, Financials, Valuation and Earnings
Last price:
$6.43
Seasonality move
:
-8.32%
Day range:
$6.34 - $6.71
52-week range:
$4.25 - $10.82
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.29x
P/B ratio:
1.29x
Volume:
417.5K
Avg. volume:
392.5K
1-year change:
-34.98%
Market cap:
$1.3B
Revenue:
$4.5B
EPS (TTM):
-$4.03
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.8B | $4.8B | $4.8B | $4.5B | $4.5B | |
| Revenue Growth (YoY) | -2.65% | 27.8% | -0.06% | -6.19% | -1.2% | |
| Cost of Revenues | $1.3B | $1.7B | $1.7B | $1.5B | $1.5B | |
| Gross Profit | $2.5B | $3.1B | $3.1B | $3B | $3B | |
| Gross Profit Margin | 66.29% | 63.94% | 63.97% | 66.59% | 66.48% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $749.2M | $922.6M | $917.2M | $827.4M | $852.8M | |
| Other Inc / (Exp) | -$696.7M | -$519.4M | -$272M | -$79M | -$532.3M | |
| Operating Expenses | $2.1B | $2.3B | $2.4B | $2.4B | $2.4B | |
| Operating Income | $398.4M | $728.8M | $705.7M | $618.3M | $528.6M | |
| Net Interest Expenses | $533.4M | $527.4M | $556.7M | $601.7M | $627.7M | |
| EBT. Incl. Unusual Items | -$831.7M | -$318M | -$123M | -$62.4M | -$631.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$27.8M | $172.6M | $84.8M | $24.4M | -$4.1M | |
| Net Income to Company | -$803.9M | -$490.6M | -$207.8M | -$86.8M | -$627.3M | |
| Minority Interest in Earnings | $121.7M | $50M | $37.1M | $13.2M | -$29.7M | |
| Net Income to Common Excl Extra Items | -$682.2M | -$440.6M | -$170.7M | -$73.6M | -$657M | |
| Basic EPS (Cont. Ops) | -$3.49 | -$1.89 | -$0.77 | -$0.35 | -$3.31 | |
| Diluted EPS (Cont. Ops) | -$3.49 | -$1.89 | -$0.77 | -$0.35 | -$3.31 | |
| Weighted Average Basic Share | $195.5M | $232.6M | $222.6M | $210M | $198.4M | |
| Weighted Average Diluted Share | $195.5M | $232.6M | $222.6M | $210M | $198.4M | |
| EBITDA | $620.4M | $1.2B | $1.3B | $1.5B | $964.6M | |
| EBIT | -$298.3M | $209.4M | $433.7M | $539.3M | -$3.7M | |
| Revenue (Reported) | $3.8B | $4.8B | $4.8B | $4.5B | $4.5B | |
| Operating Income (Reported) | $398.4M | $728.8M | $705.7M | $618.3M | $528.6M | |
| Operating Income (Adjusted) | -$298.3M | $209.4M | $433.7M | $539.3M | -$3.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Revenue Growth (YoY) | 25.16% | 4.38% | -9.43% | -0.19% | -1.45% | |
| Cost of Revenues | $410.2M | $437.2M | $364.9M | $376.3M | $347.3M | |
| Gross Profit | $755M | $779M | $736.6M | $723.1M | $736.2M | |
| Gross Profit Margin | 64.8% | 64.05% | 66.87% | 65.77% | 67.95% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $213.8M | $248.7M | $220.8M | $230.7M | $226.8M | |
| Other Inc / (Exp) | $61.5M | $53.5M | -$50.5M | $62.3M | -$98.1M | |
| Operating Expenses | $569.9M | $589.8M | $595.7M | $624.9M | $597.4M | |
| Operating Income | $185.1M | $189.2M | $140.9M | $98.2M | $138.8M | |
| Net Interest Expenses | $126.4M | $129.7M | $146.6M | $155.9M | $158.3M | |
| EBT. Incl. Unusual Items | $120.2M | $113M | -$56.2M | $4.6M | -$117.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $29.5M | $22.8M | $11.9M | $5.1M | $9.1M | |
| Net Income to Company | $90.7M | $90.2M | -$68.1M | -$500K | -$126.7M | |
| Minority Interest in Earnings | -$1.6M | -$9.6M | $2.5M | -- | -$9.7M | |
| Net Income to Common Excl Extra Items | $89.1M | $80.6M | -$65.6M | -$500K | -$136.4M | |
| Basic EPS (Cont. Ops) | $0.38 | $0.35 | -$0.30 | -- | -$0.69 | |
| Diluted EPS (Cont. Ops) | $0.38 | $0.35 | -$0.30 | -- | -$0.69 | |
| Weighted Average Basic Share | $232.4M | $228.3M | $215.7M | $203.6M | $197.5M | |
| Weighted Average Diluted Share | $253M | $249.5M | $215.7M | $203.6M | $197.5M | |
| EBITDA | $489.7M | $456.8M | $325M | $408.3M | $269.5M | |
| EBIT | $246.6M | $242.7M | $90.4M | $160.5M | $40.7M | |
| Revenue (Reported) | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Operating Income (Reported) | $185.1M | $189.2M | $140.9M | $98.2M | $138.8M | |
| Operating Income (Adjusted) | $246.6M | $242.7M | $90.4M | $160.5M | $40.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | $4.9B | $4.7B | $4.5B | $4.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.4B | $1.8B | $1.7B | $1.5B | $1.5B | |
| Gross Profit | $2.6B | $3.1B | $3B | $3B | $3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $772.6M | $957.5M | $889.3M | $837.3M | $848.9M | |
| Other Inc / (Exp) | -$499.3M | -$527.4M | -$376M | $33.8M | -$692.7M | |
| Operating Expenses | $2.1B | $2.4B | $2.4B | $2.4B | $2.4B | |
| Operating Income | $483.3M | $737.9M | $661.2M | $575.6M | $569.2M | |
| Net Interest Expenses | $516.5M | $530.7M | $573.6M | $611M | $630.1M | |
| EBT. Incl. Unusual Items | -$532.5M | -$320.2M | -$288.4M | -$1.6M | -$753.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$3.9M | $167M | $74.6M | $17.6M | -$100K | |
| Net Income to Company | -$528.6M | -$491.1M | -$366.1M | -$19.2M | -$753.5M | |
| Minority Interest in Earnings | $116.2M | $42M | $36.7M | $10.7M | -$39.4M | |
| Net Income to Common Excl Extra Items | -$412.4M | -$445.2M | -$326.3M | -$8.5M | -$792.9M | |
| Basic EPS (Cont. Ops) | -$2.10 | -$1.91 | -$1.46 | -$0.03 | -$4.03 | |
| Diluted EPS (Cont. Ops) | -$2.10 | -$1.92 | -$1.46 | -$0.04 | -$4.03 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $932.3M | $1.1B | $1.2B | $1.6B | $825.8M | |
| EBIT | -$16M | $210.5M | $285.2M | $609.4M | -$123.5M | |
| Revenue (Reported) | $4B | $4.9B | $4.7B | $4.5B | $4.4B | |
| Operating Income (Reported) | $483.3M | $737.9M | $661.2M | $575.6M | $569.2M | |
| Operating Income (Adjusted) | -$16M | $210.5M | $285.2M | $609.4M | -$123.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $410.2M | $437.2M | $364.9M | $376.3M | $347.3M | |
| Gross Profit | $755M | $779M | $736.6M | $723.1M | $736.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $213.8M | $248.7M | $220.8M | $230.7M | $226.8M | |
| Other Inc / (Exp) | $61.5M | $53.5M | -$50.5M | $62.3M | -$98.1M | |
| Operating Expenses | $569.9M | $589.8M | $595.7M | $624.9M | $597.4M | |
| Operating Income | $185.1M | $189.2M | $140.9M | $98.2M | $138.8M | |
| Net Interest Expenses | $126.4M | $129.7M | $146.6M | $155.9M | $158.3M | |
| EBT. Incl. Unusual Items | $120.2M | $113M | -$56.2M | $4.6M | -$117.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $29.5M | $22.8M | $11.9M | $5.1M | $9.1M | |
| Net Income to Company | $90.7M | $90.2M | -$68.1M | -$500K | -$126.7M | |
| Minority Interest in Earnings | -$1.6M | -$9.6M | $2.5M | -- | -$9.7M | |
| Net Income to Common Excl Extra Items | $89.1M | $80.6M | -$65.6M | -$500K | -$136.4M | |
| Basic EPS (Cont. Ops) | $0.38 | $0.35 | -$0.30 | -- | -$0.69 | |
| Diluted EPS (Cont. Ops) | $0.38 | $0.35 | -$0.30 | -- | -$0.69 | |
| Weighted Average Basic Share | $232.4M | $228.3M | $215.7M | $203.6M | $197.5M | |
| Weighted Average Diluted Share | $253M | $249.5M | $215.7M | $203.6M | $197.5M | |
| EBITDA | $489.7M | $456.8M | $325M | $408.3M | $269.5M | |
| EBIT | $246.6M | $242.7M | $90.4M | $160.5M | $40.7M | |
| Revenue (Reported) | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Operating Income (Reported) | $185.1M | $189.2M | $140.9M | $98.2M | $138.8M | |
| Operating Income (Adjusted) | $246.6M | $242.7M | $90.4M | $160.5M | $40.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $894.2M | $956.7M | $781M | $988.6M | $654.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $558.6M | $526.6M | $603.3M | $686.1M | $704.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $63.8M | $67.7M | $65.1M | $68.8M | $79.8M | |
| Other Current Assets | $353.5M | $322.5M | $338.9M | $359.5M | $396.4M | |
| Total Current Assets | $1.9B | $2.1B | $2.1B | $2.4B | $2.1B | |
| Property Plant And Equipment | $4.8B | $4.2B | $4.3B | $4.2B | $4.1B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $4.9B | $3.9B | $3.4B | $3.5B | $3B | |
| Other Intangibles | $2.3B | $2.4B | $2.3B | $2.1B | $2.2B | |
| Other Long-Term Assets | $1.2B | $2.8B | $1.5B | $1.4B | $1.4B | |
| Total Assets | $15.1B | $15.4B | $13.6B | $13.6B | $12.8B | |
| Accounts Payable | $425.3M | $398M | $525.1M | $424.4M | $441.9M | |
| Accrued Expenses | $763.8M | $780.2M | $751.1M | $849.9M | $883.9M | |
| Current Portion Of Long-Term Debt | $161.9M | $106.3M | $226.9M | $581.9M | $465.7M | |
| Current Portion Of Capital Lease Obligations | $63.2M | $82M | $76.7M | $84.3M | $87.5M | |
| Other Current Liabilities | $90.2M | -- | $42.3M | $25M | $48.6M | |
| Total Current Liabilities | $1.7B | $1.5B | $1.8B | $2.1B | $2B | |
| Long-Term Debt | $8.2B | $7.5B | $7.7B | $7.6B | $7.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $11.7B | $12.5B | $11B | $11.3B | $11.2B | |
| Common Stock | $2.3M | $2.3M | $2.3M | $2.4M | $2.4M | |
| Other Common Equity Adj | -$125.6M | -$89.7M | -$149.2M | -$198M | -$154.2M | |
| Common Equity | $2.6B | $2.2B | $1.9B | $1.8B | $1.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $729M | $677.4M | $637.9M | $546.2M | $505M | |
| Total Equity | $3.3B | $2.9B | $2.6B | $2.3B | $1.6B | |
| Total Liabilities and Equity | $15.1B | $15.4B | $13.6B | $13.6B | $12.8B | |
| Cash and Short Terms | $894.2M | $956.7M | $781M | $988.6M | $654.3M | |
| Total Debt | $8.4B | $7.6B | $7.9B | $8.2B | $8.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.3B | $856.6M | $671.8M | $668.5M | $575.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $563.4M | $548.6M | $623.7M | $707.8M | $679M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $68.4M | $72.3M | $76.6M | $92.1M | $109.4M | |
| Other Current Assets | $471.2M | $427.1M | $420.8M | $342.2M | $400.8M | |
| Total Current Assets | $2.4B | $2B | $2B | $2.1B | $2.1B | |
| Property Plant And Equipment | $4.9B | $4.1B | $4.3B | $4.1B | $4B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $4.8B | $3.9B | $3.5B | $3.5B | $3B | |
| Other Intangibles | $2.3B | $2.3B | $2.3B | $2.1B | $2.2B | |
| Other Long-Term Assets | $1.2B | $2.8B | $1.4B | $1.4B | $1.4B | |
| Total Assets | $15.5B | $15.2B | $13.4B | $13.3B | $12.6B | |
| Accounts Payable | $364.9M | $349.2M | $426.4M | $365.8M | $330.9M | |
| Accrued Expenses | $892.2M | $653.5M | $753.2M | $771.5M | $800.7M | |
| Current Portion Of Long-Term Debt | $162.8M | $117.8M | $261.4M | $465.2M | $539.2M | |
| Current Portion Of Capital Lease Obligations | -- | $78.8M | $91.9M | $87.9M | $90.3M | |
| Other Current Liabilities | $77.7M | -- | -- | $58.1M | $44.2M | |
| Total Current Liabilities | $1.7B | $1.4B | $1.7B | $1.9B | $1.9B | |
| Long-Term Debt | $8.6B | $7.5B | $7.7B | $7.6B | $7.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $12B | $12.3B | $10.9B | $11B | $11.1B | |
| Common Stock | $2.3M | $2.4M | $2.4M | $2.4M | $2.4M | |
| Other Common Equity Adj | -$150M | -$123.3M | -$126M | -$187.5M | -$139.9M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $730.4M | $686.9M | $625.7M | $545.6M | $503.9M | |
| Total Equity | $3.5B | $3B | $2.5B | $2.3B | $1.5B | |
| Total Liabilities and Equity | $15.5B | $15.2B | $13.4B | $13.3B | $12.6B | |
| Cash and Short Terms | $1.3B | $856.6M | $671.8M | $668.5M | $575.5M | |
| Total Debt | $8.8B | $7.6B | $7.9B | $8.1B | $8.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$803.9M | -$490.6M | -$207.8M | -$86.8M | -$627.3M | |
| Depreciation & Amoritzation | $918.7M | $964.7M | $910.7M | $1B | $968.3M | |
| Stock-Based Compensation | $97.5M | $118.1M | $93.5M | $88.7M | $73M | |
| Change in Accounts Receivable | -$134.1M | -$48.5M | -$85M | $51.9M | $295.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $640.1M | $1B | $868.8M | $897M | $756.3M | |
| Capital Expenditures | $565.8M | $736.3M | $660.1M | $585M | $540.4M | |
| Cash Acquisitions | -$1.9B | -$520.6M | -$419.6M | -- | -$95.4M | |
| Cash From Investing | -$2.5B | -$1.3B | -$1.1B | -$615.8M | -$688.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.3B | $1.2B | $337.6M | $1.1B | $1.7B | |
| Long-Term Debt Repaid | -$1.4B | -$632.5M | -$276.7M | -$955.9M | -$2B | |
| Repurchase of Common Stock | -$9.5M | -$63M | -$170.4M | -$118.3M | -$82.9M | |
| Other Financing Activities | $54M | -$127.3M | $80.3M | -$81M | -$46.1M | |
| Cash From Financing | $271.1M | $426.6M | -$29.2M | -$62.4M | -$386.4M | |
| Beginning Cash (CF) | $2.5B | $912.5M | $1.1B | $788.9M | $999.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.5B | $174.2M | -$283M | $218.8M | -$318.6M | |
| Ending Cash (CF) | $912.5M | $1.1B | $788.9M | $999.8M | $670.3M | |
| Levered Free Cash Flow | $74.3M | $279.9M | $208.7M | $312M | $215.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $90.7M | $90.2M | -$68.1M | -$500K | -$126.7M | |
| Depreciation & Amoritzation | $243.1M | $214.1M | $234.6M | $247.8M | $228.8M | |
| Stock-Based Compensation | $23M | $30M | $29.2M | $27M | $28.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $203.5M | $122.3M | $62.4M | $23.3M | $24.6M | |
| Capital Expenditures | $135.6M | $164.2M | $114.1M | $109.7M | $96.7M | |
| Cash Acquisitions | $20.4M | -$24.8M | -- | -- | -- | |
| Cash From Investing | -$126.4M | -$189M | -$132.1M | -$116.9M | -$95M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $696M | $38.6M | $491.4M | $46.1M | $941.5M | |
| Long-Term Debt Repaid | -$288.3M | -$50.2M | -$495.7M | -$211.4M | -$879.7M | |
| Repurchase of Common Stock | -- | -$55.3M | -$21.9M | -$56M | -- | |
| Other Financing Activities | -$74.7M | -$11.3M | -$9.2M | -$4.4M | -$58.4M | |
| Cash From Financing | $333M | -$78.2M | -$35.4M | -$225.7M | $3.4M | |
| Beginning Cash (CF) | $912.5M | $1.1B | $788.9M | $999.8M | $670.3M | |
| Foreign Exchange Rate Adjustment | $2.8M | $2M | -$4.2M | -$800K | -$11.8M | |
| Additions / Reductions | $410.1M | -$144.9M | -$105.1M | -$319.3M | -$67M | |
| Ending Cash (CF) | $1.3B | $931.3M | $679.6M | $679.7M | $591.5M | |
| Levered Free Cash Flow | $67.9M | -$41.9M | -$51.7M | -$86.4M | -$72.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$528.6M | -$491.1M | -$366.1M | -$19.2M | -$753.5M | |
| Depreciation & Amoritzation | $948.3M | $935.7M | $931.2M | $1B | $949.3M | |
| Stock-Based Compensation | $96.7M | $125.1M | $92.7M | $86.5M | $74.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $728.7M | $935M | $808.9M | $857.9M | $757.6M | |
| Capital Expenditures | $552.2M | $764.9M | $610M | $580.6M | $527.4M | |
| Cash Acquisitions | -$1.9B | -$565.8M | -$394.8M | -- | -$95.4M | |
| Cash From Investing | -$2.4B | -$1.3B | -$1.1B | -$600.6M | -$666.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.5B | $592M | $790.4M | $647.5M | $2.6B | |
| Long-Term Debt Repaid | -$1.7B | -$394.4M | -$722.2M | -$671.6M | -$2.6B | |
| Repurchase of Common Stock | -$8.1M | -$118.3M | -$137M | -$152.4M | -$26.9M | |
| Other Financing Activities | $13.3M | -$63.9M | $82.4M | -$76.2M | -$100.1M | |
| Cash From Financing | $148.7M | $15.4M | $13.6M | -$252.7M | -$157.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.6B | -$380.8M | -$243.2M | $4.6M | -$66.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $176.5M | $170.1M | $198.9M | $277.3M | $230.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $90.7M | $90.2M | -$68.1M | -$500K | -$126.7M | |
| Depreciation & Amoritzation | $243.1M | $214.1M | $234.6M | $247.8M | $228.8M | |
| Stock-Based Compensation | $23M | $30M | $29.2M | $27M | $28.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $203.5M | $122.3M | $62.4M | $23.3M | $24.6M | |
| Capital Expenditures | $135.6M | $164.2M | $114.1M | $109.7M | $96.7M | |
| Cash Acquisitions | $20.4M | -$24.8M | -- | -- | -- | |
| Cash From Investing | -$126.4M | -$189M | -$132.1M | -$116.9M | -$95M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $696M | $38.6M | $491.4M | $46.1M | $941.5M | |
| Long-Term Debt Repaid | -$288.3M | -$50.2M | -$495.7M | -$211.4M | -$879.7M | |
| Repurchase of Common Stock | -- | -$55.3M | -$21.9M | -$56M | -- | |
| Other Financing Activities | -$74.7M | -$11.3M | -$9.2M | -$4.4M | -$58.4M | |
| Cash From Financing | $333M | -$78.2M | -$35.4M | -$225.7M | $3.4M | |
| Beginning Cash (CF) | $912.5M | $1.1B | $788.9M | $999.8M | $670.3M | |
| Foreign Exchange Rate Adjustment | $2.8M | $2M | -$4.2M | -$800K | -$11.8M | |
| Additions / Reductions | $410.1M | -$144.9M | -$105.1M | -$319.3M | -$67M | |
| Ending Cash (CF) | $1.3B | $931.3M | $679.6M | $679.7M | $591.5M | |
| Levered Free Cash Flow | $67.9M | -$41.9M | -$51.7M | -$86.4M | -$72.1M | |
Get LILA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LILA
Sector
P/E ratio
--
17.70x
PEG ratio
0.00x
0.00x
P/B ratio
1.29x
1.49x
Price / LTM sales
0.29x
0.96x
Growth Metrics
LILA
Sector
Revenue growth
-1.45%
-0.53%
Earnings growth
--
-0.61%
Revenue (5-year growth)
2.88%
1.59%
Earnings forecast
--
$0.05
Profitability
LILA
Sector
Profitability FY 2024
$3B
$256.3M
Return on invested capital
-7.94%
0.79%
Return on assets
-6.14%
0.12%
Return on equity
-42.22%
2.1%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
6
Balance Sheet
LILA
Sector
Total cash
$575.5M
$97.1M
Short term investments
--
$26.8M
Total assets
$12.8B
$827.5M
Long term debt
$8.2B
$44M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
80
SOC alert for Jul 18
Sable Offshore [SOC] is up 11.86% over the past day.
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 5.56% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.31% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
